Author | Anderson, Stuart C. author |
---|---|
Title | Managing Pharmaceuticals in International Health [electronic resource] / by Stuart C. Anderson, Reinhard Huss, Robert S. Summers, Karin A. Wiedenmayer |
Imprint | Basel : Birkhauser, 2004 |
Connect to | http://dx.doi.org/10.1007/978-3-0348-7913-2 |
Descript | XIV, 232p. online resource |
1 Issues in the Management of Pharmaceuticals in International Health -- 1.1 Introduction -- 1.2 Pharmaceuticals, medicines and drugs -- 1.3 International health -- 1.4 The emergence of medicines -- 1.5 Global inequity and the medicines life cycle -- 1.6 The study of pharmaceuticals in international health -- 1.7 Approaches to managing pharmaceuticals -- 1.8 Layout of the book -- 1.9 Conclusion -- 2 Access and Availability of Pharmaceuticals in International Health -- 2.1 Introduction -- 2.2 Access to essential medicines -- 2.3 Neglected diseases -- 2.4 Strategies for developing medicines and ensuring access -- 2.5 Conclusion -- 3 Assessing the Pharmaceutical Needs of Patients and Populations -- 3.1 Introduction -- 3.2 Public health pharmacology -- 3.3 Incidence of disease -- 3.4 Needs and priorities for medicines -- 3.5 Culture and the use of medicines -- 3.6 Patients as consumers -- 3.7 Compliance, adherence and concordance -- 3.8 Empowerment -- 3.9 Conclusion -- 4 The Role of Health Professionals -- 4.1 Introduction -- 4.2 Classifying health professionals -- 4.3 Health professionals and medicine responsibilities -- 4.4 The role of the doctor -- 4.5 The role of the pharmacist -- 4.6 Traditional healers -- 4.7 Integrating traditional medicine and Western medicine -- 4.8 Conclusion -- 5 The Role of the Pharmaceutical Industry -- 5.1 Introduction -- 5.2 The origins and development of the pharmaceutical industry -- 5.3 Structure of the industry today -- 5.4 Pharmaceutical company partners -- 5.5 The activities of the industry -- 5.6 Pharmaceutical markets -- 5.7 The pharmaceutical industry and international health -- 5.8 Conclusion -- 6 The Role of Governments -- 6.1 Introduction -- 6.2 The development of national drug policies -- 6.3 The drug supply process -- 6.4 Health systems that support drug supply -- 6.5 Pharmaceutical legislation and regulation -- 6.6 Research, monitoring and evaluation -- 6.7 Conclusion -- 7 The Role of the European Union, National Assistance Agencies and NGOs -- 7.1 Introduction -- 7.2 The European Union -- 7.3 The national aid agencies -- 7.4 International and national NGOs -- 7.5 Some non-governmental organizations -- 7.6 Equitable pharmaceutical supply and distribution -- 7.7 Conclusion -- 8 The Role of International Organizations -- 8.1 Introduction -- 8.2 WHO and other UN organizations -- 8.3 Industry organizations -- 8.4 Other organizations -- 8.5 Essential drugs -- 8.6 Pharmaceutical procurement -- 8.7 International agreements and intellectual property rights -- 8.8 Case study-HIV/AIDS and antiretroviral treatment in South Africa -- 8.9 Conclusion -- 9 Rational Use of Medicines -- 9.1 Introduction -- 9.2 Consequences of non-rational medicine use -- 9.3 Medicine use behaviour -- 9.4 Investigating medicine use problems -- 9.5 Medicine use interventions -- 9.6 Effectiveness of interventions -- 9.7 Conclusion -- 10 Medicine Quality, Adverse Reactions and Antimicrobial Resistance -- 10.1 Introduction -- 10.2 Quality of medicines -- 10.3 Counterfeit medicines -- 10.4 Adverse drug reactions -- 10.5 Antimicrobial resistance -- 10.6 Conclusion -- 11 Managing Medicines Information -- 11.1 Introduction -- 11.2 The users of medicine information -- 11.3 Sources of information -- 11.4 The quality of medicines information -- 11.5 The assessment of information -- 11.6 Classification systems -- 11.7 Conclusion -- 12 Investigating the Use of Medicines -- 12.1 Introduction -- 12.2 Drug utilization studies -- 12.3 Pharmacoeconomics -- 12.4 Pharmacovigilance -- 12.5 Pharmacoepidemiology -- 12.6 Health systems and policy studies -- 12.7 Conclusion -- 13 Trends and Developments -- 13.1 Introduction -- 13.2 Trends in the use of herbal remedies -- 13.3 The contribution of pharmacogenetics and pharmacogenomics -- 13.4 The changing role of the internet -- 13.5 Changes in the health care workforce -- 13.6 Conclusion -- 14 Policy Initiatives and their Implications -- 14.1 Introduction -- 14.2 The role of public-private partnerships -- 14.3 The Global Fund and other initiatives -- 14.4 Global procurement of medicines -- 14.5 AIDS drugs post Doha -- 14.6 Conclusion -- Selected Websites and Webportals